Healthcare -
Biotechnology - NASDAQ - US
$ 2.72
-1.45 %
$ 189 M
Market Cap
-0.87
P/E
IKT - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss IKT - Inhibikase Therapeutics, Inc.
877
LAST VALUE
35132047.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR